Christopher J Rohan, MD | |
130 Fisher Rd, Central Vermont Medical Center, Berlin, VT 05602-9516 | |
(802) 371-4257 | |
Not Available |
Full Name | Christopher J Rohan |
---|---|
Gender | Male |
Speciality | Anesthesiology |
Experience | 26 Years |
Location | 130 Fisher Rd, Berlin, Vermont |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1699794875 | NPI | - | NPPES |
1008938 | Medicaid | VT | |
00058888 | Other | VT | BLUE CROSS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207L00000X | Anesthesiology | 042-0010383 (Vermont) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Medstream Anesthesia Pllc | 7416198049 | 566 |
News Archive
Healthland, America's market leader of healthcare information solutions for small community and critical access hospitals, announced today it has partnered with the Performance Management Institute (PMI), to deliver an innovative solution to small community hospitals. PMI works with numerous state networks and hospital systems to provide a platform for monitoring and performance.
University at Buffalo smoking cessation researchers today applauded federal plans to require cigarette packs and ads to carry bigger, much more prominent and graphic health warnings, including images of the destruction to the lungs caused by tobacco, which must cover half of a cigarette pack. In announcing the initiative, the Health and Human Services Department called the new warnings "the most significant change in more than 25 years" in cigarette packages and advertising.
In addition to crystallized cholesterol, atherosclerotic plaques always contain large quantities of immune cells but, surprisingly, no bacteria or viruses. It was previously unclear just how the body's own defence forces are called into action. Even animals that are kept in an absolutely sterile environment can suffer from "clogging" or "furring" of the arteries when their food contains high levels of cholesterol.
Transcept Pharmaceuticals, Inc. today announced the first patient has been enrolled in a Phase 2 clinical study to evaluate TO-2061 as an adjunctive treatment for obsessive compulsive disorder (OCD) in patients who have responded inadequately to currently approved treatments. OCD affects 1 to 2 percent of the United States adult population and can significantly impair the lives of patients and their families.
› Verified 3 days ago
Entity Name | University Of Vermont Medical Center Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1659309615 PECOS PAC ID: 3779491071 Enrollment ID: O20040406001047 |
News Archive
Healthland, America's market leader of healthcare information solutions for small community and critical access hospitals, announced today it has partnered with the Performance Management Institute (PMI), to deliver an innovative solution to small community hospitals. PMI works with numerous state networks and hospital systems to provide a platform for monitoring and performance.
University at Buffalo smoking cessation researchers today applauded federal plans to require cigarette packs and ads to carry bigger, much more prominent and graphic health warnings, including images of the destruction to the lungs caused by tobacco, which must cover half of a cigarette pack. In announcing the initiative, the Health and Human Services Department called the new warnings "the most significant change in more than 25 years" in cigarette packages and advertising.
In addition to crystallized cholesterol, atherosclerotic plaques always contain large quantities of immune cells but, surprisingly, no bacteria or viruses. It was previously unclear just how the body's own defence forces are called into action. Even animals that are kept in an absolutely sterile environment can suffer from "clogging" or "furring" of the arteries when their food contains high levels of cholesterol.
Transcept Pharmaceuticals, Inc. today announced the first patient has been enrolled in a Phase 2 clinical study to evaluate TO-2061 as an adjunctive treatment for obsessive compulsive disorder (OCD) in patients who have responded inadequately to currently approved treatments. OCD affects 1 to 2 percent of the United States adult population and can significantly impair the lives of patients and their families.
› Verified 3 days ago
Entity Name | Gifford Medical Center Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1942329446 PECOS PAC ID: 4880683663 Enrollment ID: O20040507000460 |
News Archive
Healthland, America's market leader of healthcare information solutions for small community and critical access hospitals, announced today it has partnered with the Performance Management Institute (PMI), to deliver an innovative solution to small community hospitals. PMI works with numerous state networks and hospital systems to provide a platform for monitoring and performance.
University at Buffalo smoking cessation researchers today applauded federal plans to require cigarette packs and ads to carry bigger, much more prominent and graphic health warnings, including images of the destruction to the lungs caused by tobacco, which must cover half of a cigarette pack. In announcing the initiative, the Health and Human Services Department called the new warnings "the most significant change in more than 25 years" in cigarette packages and advertising.
In addition to crystallized cholesterol, atherosclerotic plaques always contain large quantities of immune cells but, surprisingly, no bacteria or viruses. It was previously unclear just how the body's own defence forces are called into action. Even animals that are kept in an absolutely sterile environment can suffer from "clogging" or "furring" of the arteries when their food contains high levels of cholesterol.
Transcept Pharmaceuticals, Inc. today announced the first patient has been enrolled in a Phase 2 clinical study to evaluate TO-2061 as an adjunctive treatment for obsessive compulsive disorder (OCD) in patients who have responded inadequately to currently approved treatments. OCD affects 1 to 2 percent of the United States adult population and can significantly impair the lives of patients and their families.
› Verified 3 days ago
Entity Name | University Of Vermont Medical Center Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1730123241 PECOS PAC ID: 3779491071 Enrollment ID: O20060822000040 |
News Archive
Healthland, America's market leader of healthcare information solutions for small community and critical access hospitals, announced today it has partnered with the Performance Management Institute (PMI), to deliver an innovative solution to small community hospitals. PMI works with numerous state networks and hospital systems to provide a platform for monitoring and performance.
University at Buffalo smoking cessation researchers today applauded federal plans to require cigarette packs and ads to carry bigger, much more prominent and graphic health warnings, including images of the destruction to the lungs caused by tobacco, which must cover half of a cigarette pack. In announcing the initiative, the Health and Human Services Department called the new warnings "the most significant change in more than 25 years" in cigarette packages and advertising.
In addition to crystallized cholesterol, atherosclerotic plaques always contain large quantities of immune cells but, surprisingly, no bacteria or viruses. It was previously unclear just how the body's own defence forces are called into action. Even animals that are kept in an absolutely sterile environment can suffer from "clogging" or "furring" of the arteries when their food contains high levels of cholesterol.
Transcept Pharmaceuticals, Inc. today announced the first patient has been enrolled in a Phase 2 clinical study to evaluate TO-2061 as an adjunctive treatment for obsessive compulsive disorder (OCD) in patients who have responded inadequately to currently approved treatments. OCD affects 1 to 2 percent of the United States adult population and can significantly impair the lives of patients and their families.
› Verified 3 days ago
Entity Name | Medstream Anesthesia Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1649616160 PECOS PAC ID: 7416198049 Enrollment ID: O20201223000259 |
News Archive
Healthland, America's market leader of healthcare information solutions for small community and critical access hospitals, announced today it has partnered with the Performance Management Institute (PMI), to deliver an innovative solution to small community hospitals. PMI works with numerous state networks and hospital systems to provide a platform for monitoring and performance.
University at Buffalo smoking cessation researchers today applauded federal plans to require cigarette packs and ads to carry bigger, much more prominent and graphic health warnings, including images of the destruction to the lungs caused by tobacco, which must cover half of a cigarette pack. In announcing the initiative, the Health and Human Services Department called the new warnings "the most significant change in more than 25 years" in cigarette packages and advertising.
In addition to crystallized cholesterol, atherosclerotic plaques always contain large quantities of immune cells but, surprisingly, no bacteria or viruses. It was previously unclear just how the body's own defence forces are called into action. Even animals that are kept in an absolutely sterile environment can suffer from "clogging" or "furring" of the arteries when their food contains high levels of cholesterol.
Transcept Pharmaceuticals, Inc. today announced the first patient has been enrolled in a Phase 2 clinical study to evaluate TO-2061 as an adjunctive treatment for obsessive compulsive disorder (OCD) in patients who have responded inadequately to currently approved treatments. OCD affects 1 to 2 percent of the United States adult population and can significantly impair the lives of patients and their families.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Christopher J Rohan, MD Po Box 297, Waitsfield, VT 05673-0297 Ph: (802) 496-6161 | Christopher J Rohan, MD 130 Fisher Rd, Central Vermont Medical Center, Berlin, VT 05602-9516 Ph: (802) 371-4257 |
News Archive
Healthland, America's market leader of healthcare information solutions for small community and critical access hospitals, announced today it has partnered with the Performance Management Institute (PMI), to deliver an innovative solution to small community hospitals. PMI works with numerous state networks and hospital systems to provide a platform for monitoring and performance.
University at Buffalo smoking cessation researchers today applauded federal plans to require cigarette packs and ads to carry bigger, much more prominent and graphic health warnings, including images of the destruction to the lungs caused by tobacco, which must cover half of a cigarette pack. In announcing the initiative, the Health and Human Services Department called the new warnings "the most significant change in more than 25 years" in cigarette packages and advertising.
In addition to crystallized cholesterol, atherosclerotic plaques always contain large quantities of immune cells but, surprisingly, no bacteria or viruses. It was previously unclear just how the body's own defence forces are called into action. Even animals that are kept in an absolutely sterile environment can suffer from "clogging" or "furring" of the arteries when their food contains high levels of cholesterol.
Transcept Pharmaceuticals, Inc. today announced the first patient has been enrolled in a Phase 2 clinical study to evaluate TO-2061 as an adjunctive treatment for obsessive compulsive disorder (OCD) in patients who have responded inadequately to currently approved treatments. OCD affects 1 to 2 percent of the United States adult population and can significantly impair the lives of patients and their families.
› Verified 3 days ago
Michael William Abajian, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 130 Fisher Road, Central Vermont Medical Center, Berlin, VT 05641 Phone: 802-371-4257 | |
Andre Breidenthal Gilbert, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 130 Fisher Rd, Central Vermont Medical Center, Berlin, VT 05602 Phone: 802-371-4257 | |
Maria C. Aveni, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 130 Fisher Rd, Central Vermont Medical Center, Berlin, VT 05602 Phone: 802-371-4257 | |
Richard Bradford Watson, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 130 Fisher Rd, Central Vermont Medical Center, Berlin, VT 05602 Phone: 802-371-4257 | |
Dr. James E. Wolf, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 130 Fisher Rd., Uvm Medical Network/cvmc Anesthesiology, Berlin, VT 05602 Phone: 802-371-4100 | |
Marie L Zagroba, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 130 Fisher Rd, Central Vt Medical Center, Berlin, VT 05602 Phone: 802-371-4257 |